When low AMH and primary ovarian failure signal the end of natural fertility, stem cell and PRP-based ovarian rejuvenation offers a revolutionary pathway. Dr. Adnan Jabbar is pioneering these cutting-edge regenerative protocols in Lahore, Pakistan — aiming to reactivate primordial follicles and restore ovarian function where conventional medicine has reached its limits.
Growth factors from stem cells and PRP can penetrate the ovarian cortex, reactivating dormant primordial follicles that standard IVF cannot reach.
Even in women diagnosed with "depleted" ovarian reserve, the ovarian cortex may harbor dormant primordial follicles that standard gonadotropin stimulation simply cannot activate. Stem cell and PRP-based rejuvenation works by creating a molecularly enriched microenvironment that kickstarts these sleeping follicles.
Platelet-Rich Plasma concentrated from the patient's own blood is injected directly into the ovarian cortex under ultrasound guidance. The concentrated growth factors stimulate local follicle recruitment.
Adipose-Derived Stem Cells harvested via mini-liposuction are processed and injected into the ovaries, providing sustained paracrine stimulation far more potent than PRP alone.
Mesenchymal stem cell-derived exosomes deliver targeted molecular signals to repair the ovarian niche, with early data showing AMH improvements in 40-60% of patients.
Rejuvenation timelines and realistic expectations based on current clinical data.
Initial hormonal changes may begin to appear on blood work (rising estradiol, slight AMH increase).
Ultrasound may reveal new antral follicles developing. Menstrual cycles may resume in amenorrheic patients.
Optimal window for IVF stimulation. Follicles recruited by stem cells/PRP are now mature enough for retrieval.
Published data shows measurable ovarian response in 40-60% of treated patients with DOR/POI.
While stem cell-based ovarian rejuvenation remains at the frontier of reproductive medicine globally, Dr. Adnan Jabbar is one of the very few specialists in Pakistan actively offering these protocols. His integrated approach combines Ovarian PRP with ADSC injection and subsequent tailored IVF stimulation — giving women with extremely low AMH and premature ovarian failure a fighting chance at biological motherhood. His clinic in Lahore has become a destination for patients who have been turned away by conventional fertility centers across Pakistan.
When using autologous stem cells (from the patient's own fat tissue), there is zero risk of immunological rejection. The procedure is minimally invasive, performed under light sedation, with minimal recovery time. No carcinogenic risks have been reported in clinical studies to date.
PRP is derived from blood platelets and provides a concentrated burst of growth factors. Stem cells (ADSCs/MSCs) provide a more sustained, multi-modal regenerative effect including paracrine signaling, exosome release, and potential cellular replacement. Dr. Adnan Jabbar often combines both for maximum impact.
Women with low AMH (<1.0 ng/mL), diminished ovarian reserve, premature ovarian insufficiency (POI), poor IVF response, or those who wish to try conception with their own eggs before resorting to donor eggs. Age under 45 generally provides the best outcomes.
Stem cell ovarian rejuvenation has given hope to women worldwide who were told their egg supply was exhausted. Dr. Adnan Jabbar brings this frontier science to Lahore.